11-Jul-2022 | Zion Market Research
With a compound annual growth rate (CAGR) of around 7.9 percent during the projected period, the global bioactive wound management market is predicted to increase in value from USD 1.8 billion in 2021 to USD 2.9 billion by 2028. Bioactive dressings are those that either release bioactive molecules directly to the wound or are made from materials with endogenous activity. These substances include biotextiles, alginates, collagens, chitosan, chitin, and derivatives of those substances. These bioactive dressings are often classified as interactive wound and burn dressings by the US Food and Drug Administration (FDA).
The aging population, rising rates of tissue abnormalities, and rising numbers of chronic wounds are all contributing to the growth of the global bioactive wound management market. Pressure ulcers, venous leg ulcers, and diabetic foot ulcers are all on the rise as a result of the increasing prevalence of lifestyle-related illnesses, particularly diabetes. By 2045, there will be 700 million adults (above 20 years) who now have diabetes, up from roughly 450 million in 2020. These figures also suggest that Type II diabetes patients are becoming more prevalent worldwide. The global market for bioactive wound management will continue to rise unabatedly as a result of these expanding situations. Skin damage and wound infection are also significantly contributing to the expansion of the market. Meanwhile, the necessity for effective treatment and management to reduce infection opens the door for bioactive wound care management solutions. Wound infection is one of the major issues for both healthcare professionals and patients around the world.
Global bioactive wound management market has transformed as a result of the COVID-19 pandemic. Numerous hospitals and departments have had their patient profiles for COVID-19 patients revised as a result of the increased demand brought on by the rising incidence of COVID-19 hospitalizations. In order to reserve or redirect the limited capabilities and resources (such as hospital beds and patient care experts) toward COVID-19 patient care, many elective procedures were canceled or postponed globally. This in turn affected the revenue flow during the pandemic period.
The global bioactive wound management market is divided into product, end-user, and region. Based on the product, the global market is categorized into hydrocolloids dressing, antimicrobial dressing, and alginate dressing. The end user segment comprises home care settings, long-term patient care, clinics, hospitals, and others.
North America dominates the global bioactive wound management market with more than 35 percent share in 2021. Bioactive wound care products saw widespread use in North America, particularly in the United States. This industry is well-positioned for growth in this region because of an advanced healthcare system, a good reimbursement system, and higher patient awareness levels. Additionally, the region's high healthcare spending has aided in the continued growth of the healthcare industry. Additionally, the rising usability of injury-related items in the home healthcare field is fostering this sector's expansion. Over the projection period, Asia Pacific is predicted to have expanded at a profitable pace. In these developing countries, the target demographic is increasingly made up of people who have infections, diabetic foot, and pressure ulcers.
Major players operating in the global bioactive wound management market include Systagenix Wound Management Ltd., Paul Hartmann AG, Mlnlycke Health Care AB, Smith & Nephew plc., ConvaTec Inc., Derma Sciences, Covalon Technologies Ltd., 3M Healthcare, Covidien plc, and Organogenesis Inc., among others.
Recent Developments:
Browse the full “Bioactive Wound Management Market By Product (Alginate Dressing, Antimicrobial Dressing, and Hydrocolloids Dressing), End-User (Hospitals, Clinics, Long-term Patient Care, Home Care Settings, and Other), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/bioactive-wound-management-market
Global bioactive wound management market is segmented as follows:
By Product
By End User
By Region
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed